{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:00:03Z","timestamp":1770814803104,"version":"3.50.1"},"reference-count":50,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,9,15]]},"abstract":"<jats:p>Genetic Creutzfeldt\u2013Jakob disease, Gerstmann\u2013Str\u00e4ussler\u2013Scheinker syndrome, fatal familial insomnia and prion protein cerebral amyloid angiopathy are clinically and neuropathologically distinct neurodegenerative diseases linked to mutations in the PRNP gene encoding the cellular prion protein (PrPC). How sequence variants of PRNP encode the information to specify these disease phenotypes is not known. It is suggested that each mutation produces a misfolded variant of PrPC with specific neurotoxic properties. However, structural studies of recombinant PrP did not detect major differences between wild-type and mutant molecules, pointing to the importance of investigating mutant PrPs from mammalian brains. We used surface plasmon resonance and a slot-blot immunoassay to analyse the antibody-binding profiles of soluble and insoluble PrP molecules extracted from the brains of transgenic mice modelling different prion diseases. By measuring the reactivity of monoclonal antibodies against different PrP epitopes, we obtained evidence of conformational differences between wild-type and mutant PrPs, and among different mutants. We detected structural heterogeneity in both monomeric and aggregated PrP, supporting the hypothesis that the phenotype of genetic prion diseases is encoded by mutant PrP conformation and assembly state.<\/jats:p>","DOI":"10.1042\/bj20130563","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T10:56:41Z","timestamp":1372676201000},"page":"417-425","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases"],"prefix":"10.1042","volume":"454","author":[{"given":"Laura","family":"Tapella","sequence":"first","affiliation":[{"name":"Dulbecco Telethon Institute c\/o Department of Neuroscience, IRCCS\u2013Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milano 20156, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Stravalaci","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, IRCCS\u2013Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milano 20156, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Bastone","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, IRCCS\u2013Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milano 20156, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Biasini","sequence":"additional","affiliation":[{"name":"Dulbecco Telethon Institute c\/o Department of Neuroscience, IRCCS\u2013Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milano 20156, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, IRCCS\u2013Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milano 20156, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Chiesa","sequence":"additional","affiliation":[{"name":"Dulbecco Telethon Institute c\/o Department of Neuroscience, IRCCS\u2013Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milano 20156, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2013,8,29]]},"reference":[{"key":"2021112215460121100_B1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/GIM.0b013e3181cd7374","article-title":"The genetics of prion diseases","volume":"12","author":"Mastrianni","year":"2010","journal-title":"Genet. Med."},{"key":"2021112215460121100_B2","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112215460121100_B3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1212\/WNL.46.2.532","article-title":"Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents","volume":"46","author":"Tateishi","year":"1996","journal-title":"Neurology"},{"key":"2021112215460121100_B4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1006\/nbdi.2001.0433","article-title":"Prion diseases: what is the neurotoxic molecule?","volume":"8","author":"Chiesa","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"2021112215460121100_B5","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1128\/JVI.77.13.7611-7622.2003","article-title":"Molecular distinction between pathogenic and infectious properties of the prion protein","volume":"77","author":"Chiesa","year":"2003","journal-title":"J. Virol."},{"key":"2021112215460121100_B6","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1038\/sj.emboj.7600717","article-title":"Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice","volume":"24","author":"Nazor","year":"2005","journal-title":"EMBO J."},{"key":"2021112215460121100_B7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1471-4159.2007.05082.x","article-title":"Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion","volume":"104","author":"Biasini","year":"2008","journal-title":"J. Neurochem."},{"key":"2021112215460121100_B8","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1073\/pnas.95.20.11667","article-title":"Prion protein NMR structure and familial human spongiform encephalopathies","volume":"95","author":"Riek","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112215460121100_B9","doi-asserted-by":"crossref","first-page":"31048","DOI":"10.1074\/jbc.273.47.31048","article-title":"Familial mutations and the thermodynamic stability of the recombinant human prion protein","volume":"273","author":"Swietnicki","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021112215460121100_B10","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1021\/bi982714g","article-title":"Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein","volume":"38","author":"Liemann","year":"1999","journal-title":"Biochemistry"},{"key":"2021112215460121100_B11","doi-asserted-by":"crossref","first-page":"33650","DOI":"10.1074\/jbc.C000483200","article-title":"Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases","volume":"275","author":"Zhang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021112215460121100_B12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/emboj.2009.333","article-title":"Conformational diversity in prion protein variants influences intermolecular \u03b2-sheet formation","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"key":"2021112215460121100_B13","doi-asserted-by":"crossref","first-page":"e11715","DOI":"10.1371\/journal.pone.0011715","article-title":"NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features","volume":"5","author":"Ilc","year":"2010","journal-title":"PLoS ONE"},{"key":"2021112215460121100_B14","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1021\/bi3009856","article-title":"Structural rearrangements at physiological pH: nuclear magnetic resonance insights from the V210I human prion protein mutant","volume":"51","author":"Biljan","year":"2012","journal-title":"Biochemistry"},{"key":"2021112215460121100_B15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0896-6273(00)80653-4","article-title":"Neurological illness in transgenic mice expressing a prion protein with an insertional mutation","volume":"21","author":"Chiesa","year":"1998","journal-title":"Neuron"},{"key":"2021112215460121100_B16","doi-asserted-by":"crossref","first-page":"11320","DOI":"10.1074\/jbc.M412441200","article-title":"Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations","volume":"280","author":"Fioriti","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112215460121100_B17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuron.2008.09.008","article-title":"Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model","volume":"60","author":"Dossena","year":"2008","journal-title":"Neuron"},{"key":"2021112215460121100_B18","doi-asserted-by":"crossref","first-page":"e7816","DOI":"10.1371\/journal.pone.0007816","article-title":"Immunopurification of pathological prion protein aggregates","volume":"4","author":"Biasini","year":"2009","journal-title":"PLoS ONE"},{"key":"2021112215460121100_B19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ab.2006.08.005","article-title":"Exploring \u201cone-shot\u201d kinetics and small molecule analysis using the ProteOn XPR36 array biosensor","volume":"358","author":"Bravman","year":"2006","journal-title":"Anal. Biochem."},{"key":"2021112215460121100_B20","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-\u03b2 oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112215460121100_B21","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1128\/jvi.61.12.3688-3693.1987","article-title":"Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins","volume":"61","author":"Kascsak","year":"1987","journal-title":"J. Virol."},{"key":"2021112215460121100_B22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1189\/jlb.1106665","article-title":"CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils","volume":"81","author":"Spinner","year":"2007","journal-title":"J. Leukocyte Biol."},{"key":"2021112215460121100_B23","doi-asserted-by":"crossref","first-page":"le5","DOI":"10.1074\/jbc.L109.088831","article-title":"Reiterating the epitope specificity of prion-specific mAb 3F4","volume":"285","author":"Kascsak","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2021112215460121100_B24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcpa.2004.06.004","article-title":"Immunohistochemical distinction between preclinical bovine spongiform encephalopathy and scrapie infection in sheep","volume":"132","author":"Thuring","year":"2005","journal-title":"J. Comput. Pathol."},{"key":"2021112215460121100_B25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1746-6148-2-19","article-title":"Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep","volume":"2","author":"Langeveld","year":"2006","journal-title":"BMC Vet. Res."},{"key":"2021112215460121100_B26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jim.2012.03.004","article-title":"All major prion types\u00a0recognised by a multiplex immunofluorometric assay for disease screening and confirmation in sheep","volume":"380","author":"Tang","year":"2012","journal-title":"J. Immunol. Methods."},{"key":"2021112215460121100_B27","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1073\/pnas.95.15.8812","article-title":"Prion protein expression in different species: analysis with a panel of new mAbs","volume":"95","author":"Zanusso","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112215460121100_B28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-4159.2004.02582.x","article-title":"Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion","volume":"90","author":"Pan","year":"2004","journal-title":"J. Neurochem."},{"key":"2021112215460121100_B29","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.79.19.12355-12364.2005","article-title":"An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrPSc aggregates","volume":"79","author":"Pan","year":"2005","journal-title":"J. Virol."},{"key":"2021112215460121100_B30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1440-1711.2005.01384.x","article-title":"Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP","volume":"83","author":"Yuan","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"2021112215460121100_B31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virol.2003.10.026","article-title":"Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies","volume":"320","author":"Kim","year":"2004","journal-title":"Virology"},{"key":"2021112215460121100_B32","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1074\/jbc.M407006200","article-title":"Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells","volume":"280","author":"Feraudet","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112215460121100_B33","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1471-4159.2008.05306.x","article-title":"Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies","volume":"105","author":"Biasini","year":"2008","journal-title":"J. Neurochem."},{"key":"2021112215460121100_B34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/2654","article-title":"Eight prion strains have PrPSc molecules with different conformations","volume":"4","author":"Safar","year":"1998","journal-title":"Nat. Med."},{"key":"2021112215460121100_B35","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1128\/JVI.01057-10","article-title":"Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay","volume":"84","author":"Choi","year":"2010","journal-title":"J. Virol."},{"key":"2021112215460121100_B36","doi-asserted-by":"crossref","first-page":"e1002242","DOI":"10.1371\/journal.ppat.1002242","article-title":"Protease-sensitive conformers in broad spectrum of distinct PrP structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate","volume":"7","author":"Kim","year":"2011","journal-title":"PLoS Pathog."},{"key":"2021112215460121100_B37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm0196-59","article-title":"Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease","volume":"2","author":"Gabizon","year":"1996","journal-title":"Nat. Med."},{"key":"2021112215460121100_B38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm0597-521","article-title":"Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients","volume":"3","author":"Silvestrini","year":"1997","journal-title":"Nat. Med."},{"key":"2021112215460121100_B39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm0997-1009","article-title":"Allelic origin of the abnormal prion protein isoform in familial prion diseases","volume":"3","author":"Chen","year":"1997","journal-title":"Nat. Med."},{"key":"2021112215460121100_B40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.20327","article-title":"Striking PrPSc heterogeneity in inherited prion diseases with the D178N mutation","volume":"56","author":"Haik","year":"2004","journal-title":"Ann. Neurol."},{"key":"2021112215460121100_B41","doi-asserted-by":"crossref","first-page":"e32382","DOI":"10.1371\/journal.pone.0032382","article-title":"Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Straussler-Scheinker disease with the P102L mutation","volume":"7","author":"Monaco","year":"2012","journal-title":"PLoS ONE"},{"key":"2021112215460121100_B42","doi-asserted-by":"crossref","first-page":"38533","DOI":"10.1074\/jbc.M111.265645","article-title":"Copper alters aggregation behavior of prion protein and induces novel interactions between its N- and C-terminal regions","volume":"286","author":"Thakur","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021112215460121100_B43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.str.2012.12.002","article-title":"Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface","volume":"21","author":"Spevacek","year":"2012","journal-title":"Structure"},{"key":"2021112215460121100_B44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.3986","article-title":"Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus","volume":"301","author":"Li","year":"2000","journal-title":"J. Mol. Biol."},{"key":"2021112215460121100_B45","doi-asserted-by":"crossref","first-page":"e19093","DOI":"10.1371\/journal.pone.0019093","article-title":"Dynamic diagnosis of familial prion diseases supports the \u03b22-\u03b12 loop as a universal interference target","volume":"6","author":"Meli","year":"2011","journal-title":"PLoS ONE"},{"key":"2021112215460121100_B46","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1096\/fj.09-153924","article-title":"The oligomerization properties of prion protein are restricted to the H2H3 domain","volume":"24","author":"Chakroun","year":"2010","journal-title":"FASEB J."},{"key":"2021112215460121100_B47","doi-asserted-by":"crossref","first-page":"21004","DOI":"10.1074\/jbc.M110.111815","article-title":"Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3","volume":"285","author":"Adrover","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2021112215460121100_B48","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00018-009-0031-5","article-title":"Aptamers against prion proteins and prions","volume":"66","author":"Gilch","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"2021112215460121100_B49","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1021\/bi051455+","article-title":"Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231","volume":"44","author":"Apetri","year":"2005","journal-title":"Biochemistry"},{"key":"2021112215460121100_B50","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1073\/pnas.0610827104","article-title":"Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans","volume":"104","author":"Yin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/454\/3\/417\/677046\/bj4540417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/454\/3\/417\/677046\/bj4540417.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T22:07:48Z","timestamp":1637618868000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/454\/3\/417\/46362\/Epitope-scanning-indicates-structural-differences"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,29]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20130563","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,29]]}}}